Technology Listings


David Lambeth

David Lambeth is a Professor in the Department of Pathology & Laboratory Medicine at the Emory University School of Medicine, where he specializes in Cancer Biology, Cardiovascular Biology, and Experimental Pathology. His research work operates out of the Lambeth Lab, which he heads as principal investigator. There, he studies reactive oxygen species and their biological roles in processes such as innate immunity and mitogenic growth. For roughly the past two decades, the lab has focused on a family of reactive oxygen species generating enzymes it had discovered that have been found as novel targets for the development of anti-cancer and anti-arteriosclerotic drugs. Over the course of his career, Lambeth has authored 10 patents.

 

http://pathology.emory.edu/AdminFacultyMember.cfm?Name_seq=710

TECHNOLOGIES
Mitogenic Oxygenase Regulators for Drug Discovery
P41nox: A Regulatory Protein for Nox Enzymes
Nox-1 Expressing Mice as an Animal Model for Colon Cancer
Mitogenic Regulators and Targets for Drug Development
Nox cDNA and Enzymes for Drug Discovery, for Diagnostics, and as Research Tools
Novel Inhibitors of NOX2/ROS
SECTORS
CATEGORIES
Diagnostics
Drug Discovery
Medical
Medical Device
Micro and Nanotechnology
Non-Therapeutics
Research Tools
Software
Therapeutics
Vaccines